# Guatemala Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Guatemala HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Guatemala (GTM)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $46.9M
- Products: 27
- Buyer markets: 24
- Average CAGR: +10.6%
- Global sector size: $453.3B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $280.6B | $7.8M | $100.4B | -12.6% | 19 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $30.4B | $1.2M | $16.7B | +36.3% | 7 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $23.5B | $903.0K | $15.0B | +2.2% | 7 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $8.5B | $28.1M | $10.9B | +11.3% | 4 | +0.3% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $25.4B | $653.5K | $10.9B | +24.6% | 8 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $13.7B | $23.1K | $6.4B | +19.7% | 3 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $13.5B | $114.9K | $5.4B | +4.9% | 4 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $6.6B | $1.6M | $4.1B | +12.8% | 2 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $7.6B | $576.0 | $3.9B | -7.1% | 2 | +0.0% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $4.3B | $736.7 | $3.4B | +18.2% | 2 | +0.0% |
| HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $3.5B | $9.2K | $3.2B | +171.5% | 1 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $8.0B | $1.1K | $2.9B | -3.3% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $2.9K | $2.2B | -18.4% | 2 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $2.3B | $5.8M | $2.1B | +4.7% | 2 | +0.3% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $1.3K | $2.0B | -2.9% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $45.9K | $1.9B | +20.6% | 1 | +0.0% |
| HS 380893 - Herbicides, anti-sprouting products and plant-growth regulators: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $2.0B | $113.0K | $1.7B | +91.8% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $3.9B | $38.6K | $1.7B | +9.8% | 2 | +0.0% |
| HS 290110 - Acyclic hydrocarbons: saturated | $916.4M | $1.7K | $1.3B | +20.4% | 1 | +0.0% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $16.1K | $990.0M | +31.8% | 1 | +0.0% |
| HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $1.6B | $157.8K | $871.0M | +54.7% | 1 | +0.0% |
| HS 300449 - Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | $1.5B | $269.3K | $841.2M | +30.1% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $35.6K | $803.3M | +15.2% | 1 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $734.9M | $7.0K | $798.7M | +13.4% | 1 | +0.0% |
| HS 380891 - Insecticides: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $1.6B | $361.8 | $713.1M | +8.1% | 1 | +0.0% |
| HS 284440 - Radioactive elements, isotopes, compounds, n.e.c. in heading no. 2844 alloys, dispersions (including cermets), ceramic products and mixtures containing these elements, isotopes or compounds: radioactive residues | $927.2M | $451.2 | $685.2M | -10.2% | 1 | +0.0% |
| HS 340600 - Candles, tapers and the like | $1.0B | $2.7K | $640.9M | -0.8% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $56.0B calculated opportunity across 18 products.
- Switzerland, Liechtenstein (CHE): $33.9B calculated opportunity across 3 products.
- Germany (DEU): $19.4B calculated opportunity across 10 products.
- China (CHN): $10.1B calculated opportunity across 4 products.
- Spain (ESP): $9.5B calculated opportunity across 5 products.
- Canada (CAN): $9.0B calculated opportunity across 6 products.
- France (FRA): $8.8B calculated opportunity across 6 products.
- Belgium (BEL): $8.2B calculated opportunity across 2 products.
- Mexico (MEX): $6.9B calculated opportunity across 3 products.
- Netherlands (NLD): $5.3B calculated opportunity across 1 products.
- Italy (ITA): $4.9B calculated opportunity across 1 products.
- Japan (JPN): $4.4B calculated opportunity across 2 products.

## Growth stars

- HS 293359: +171.5% average CAGR, $3.2B calculated opportunity.
- HS 380893: +91.8% average CAGR, $1.7B calculated opportunity.
- HS 293339: +54.7% average CAGR, $871.0M calculated opportunity.
- HS 300212: +36.3% average CAGR, $16.7B calculated opportunity.
- HS 294190: +31.8% average CAGR, $990.0M calculated opportunity.
- HS 300449: +30.1% average CAGR, $841.2M calculated opportunity.
- HS 330499: +24.6% average CAGR, $10.9B calculated opportunity.
- HS 382319: +20.6% average CAGR, $1.9B calculated opportunity.
- HS 290110: +20.4% average CAGR, $1.3B calculated opportunity.
- HS 300439: +19.7% average CAGR, $6.4B calculated opportunity.

## Diversification opportunities

- HS 300490: 19 buyer markets, $100.4B calculated opportunity.
- HS 330499: 8 buyer markets, $10.9B calculated opportunity.
- HS 300212: 7 buyer markets, $16.7B calculated opportunity.
- HS 382499: 7 buyer markets, $15.0B calculated opportunity.
- HS 330210: 4 buyer markets, $10.9B calculated opportunity.
- HS 382200: 4 buyer markets, $5.4B calculated opportunity.
- HS 300439: 3 buyer markets, $6.4B calculated opportunity.
- HS 330300: 2 buyer markets, $4.1B calculated opportunity.
- HS 293499: 2 buyer markets, $3.9B calculated opportunity.
- HS 382600: 2 buyer markets, $3.4B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.